Apolipoprotein E4 Polymorphism and Outcomes from Traumatic Brain Injury: A Living Systematic Review and Meta-Analysis
Open accessThe DOI matches its Crossref record; 13 of the 13 references it cites were found in a registry or an index.
Abstract
The mortality of traumatic brain injury (TBI) has been largely static despite advances in monitoring and imaging techniques. Substantial variance exists in outcome, not fully accounted for by baseline characteristics or injury severity, and genetic factors likely play a role in this variance. The aims of this systematic review were to examine the evidence for a link between the apolipoprotein E4 (APOE4) polymorphism and TBI outcomes and where possible, to quantify the effect size via meta-analysis. We searched EMBASE, MEDLINE, CINAHL, and gray literature in December 2017. We included studies of APOE genotype in relation to functional adult TBI outcomes. Methodological quality was assessed using the Quality in Prognostic Studies Risk of Bias Assessment Instrument and the prognostic studies adaptation of the Grading of Recommendations Assessment, Development and Evaluation tool. In addition, we contacted investigators and included an additional 160 patients whose data had not been made available for previous analyses, giving a total sample size of 2593 patients. Meta-analysis demonstrated higher odds of a favorable outcome following TBI in those not possessing an ApoE ɛ4 allele compared with ɛ4 carriers and homozygotes (odds ratio 1.39, 95% confidence interval 1.05 to 1.84; p = 0.02). The influence of APOE4 on neuropsychological functioning following TBI remained uncertain, with multiple conflicting studies. We conclude that the ApoE ɛ4 allele confers a small risk of poor outcome following TBI, with analysis by TBI severity not possible based on the currently available published data. Further research into the long-term neuropsychological impact and risk of dementia is warranted.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Assessing Bias in Studies of Prognostic Factors
Hayden, J. A., van der Windt, D. A., Cartwright, J. L., Côté, P., & Bombardier, C. (2013) · Annals of Internal Medicine · doi:10.7326/0003-4819-158-4-201302190-00009 · Cited by 3,287 · cited 1×
“Risk of bias was assessed using the Quality In Prognostic Studies (QuIPS) criteria, a validated domain-based tool for quality assessment of prognostic studies.(14) Two authors (CAM and VFJN/FAZ) independently completed the QuIPS for each study, and then reached a final judgement on each of the six domains by consensus.”
MethodLohmueller, K. E., Pearce, C. L., Pike, M., Lander, E. S., & Hirschhorn, J. N. (2003) · Nature Genetics · doi:10.1038/ng1071 · Cited by 1,900
A comprehensive review of genetic association studies
Hirschhorn, J. N., Lohmueller, K., Byrne, E., & Hirschhorn, K. (2002) · Genetics in Medicine · doi:10.1097/00125817-200203000-00002 · Cited by 1,674
Duncan, L. E., & Keller, M. C. (2011) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2011.11020191 · Cited by 1,032 · cited 1×
“We note that publication bias for positive candidate gene association studies has been demonstrated in other clinical contexts.(71,72) Our funnel plot (Fig.”
ResultApolipoprotein E in Alzheimer’s disease and other neurological disorders
Verghese, P. B., Castellano, J. M., & Holtzman, D. M. (2011) · The Lancet Neurology · doi:10.1016/s1474-4422(10)70325-2 · Cited by 857 · cited 1×
“The literature to date supports an association between possession of the e4 allele and a variety of negative neuropsychiatric outcomes, including a dosedependent increase in the risk of late onset Alzheimer’s disease as well as intracerebral haemorrhage.(4) There is some evidence that APOE2 may exert a neuroprotective…”
BackgroundInflammation and neuroprotection in traumatic brain injury.
Corps, K. N., Roth, T. L., & McGavern, D. B. (2015) · JAMA Neurology · doi:10.1001/jamaneurol.2014.3558 · Cited by 853 · cited 1×
“Traumatic brain injury involves a mechanical insult triggering a complex pathogenic process, with inflammation and neurotoxicity featuring prominently in the development of secondary brain injury.(6) As the E4 isoform has been shown to exhibit”
BackgroundLiving Systematic Reviews: An Emerging Opportunity to Narrow the Evidence-Practice Gap
Elliott, J. H., Turner, T., Clavisi, O., Thomas, J., Higgins, J. P. T., Mavergames, C., & Gruen, R. L. (2014) · PLoS Medicine · doi:10.1371/journal.pmed.1001603 · Cited by 596 · cited 1×
“A living systematic review is a high quality up-to-date online summary of health research that is updated as new research becomes available.(13) In practice, this means that the searches will be re-run and any new studies incorporated into the review.”
BackgroundSelf-citationHuguet, A., Hayden, J. A., Stinson, J., McGrath, P. J., Chambers, C. T., Tougas, M. E., & Wozney, L. (2013) · Systematic Reviews · doi:10.1186/2046-4053-2-71 · Cited by 531
Apolipoprotein E ε4 allele is associated with deposition of amyloid β-protein following head injury
Nicoll, J. A. R., Roberts, G. W., & Graham, D. I. (1995) · Nature Medicine · doi:10.1038/nm0295-135 · Cited by 486
Apolipoprotein e sets the stage: response to injury triggers neuropathology
Mahley, R. W., & Huang, Y. (2012) · Neuron · doi:10.1016/j.neuron.2012.11.020 · Cited by 412
Cited by
Traumatic brain injury: progress and challenges in prevention, clinical care, and research
Maas, A. I. R., Menon, D. K., Manley, G. T., Abrams, M., Åkerlund, C., Andelic, N., Aries, M., Bashford, T., Bell, M. J., Bodien, Y. G., et al. (2022) · The Lancet Neurology · doi:10.1016/s1474-4422(22)00309-x · Cited by 1,520
Self-citationFernández-Calle, R., Konings, S. C., Frontiñán-Rubio, J., García-Revilla, J., Camprubí-Ferrer, L., Svensson, M., Martinson, I., Boza-Serrano, A., Venero, J. L., Nielsen, H. M., et al. (2022) · Molecular Neurodegeneration · doi:10.1186/s13024-022-00566-4 · Cited by 278
ApoE Lipidation as a therapeutic target in Alzheimer’s disease
Lanfranco, M. F., Ng, C. A., & Rebeck, G. W. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21176336 · Cited by 189
“APOE4 also affects other neurological disorders, including poor clinical outcomes after traumatic brain injury or stroke [5,6], frontotemporal dementia [7,8], Down syndrome [9], and Lewy body disease [10].”
BackgroundAssociation of APOE Genotypes and Chronic Traumatic Encephalopathy
Atherton, K., Han, X., Chung, J., Cherry, J. D., Baucom, Z., Saltiel, N., Nair, E., Abdolmohammadi, B., Uretsky, M., Khan, M. M., et al. (2022) · JAMA Neurology · doi:10.1001/jamaneurol.2022.1634 · Cited by 70
Past, present and future of living systematic review: a bibliometrics analysis
Zheng, Q., Xu, J., Gao, Y., Liu, M., Cheng, L., Xiong, L., Cheng, J., Yuan, M., OuYang, G., Huang, H., et al. (2022) · BMJ Global Health · doi:10.1136/bmjgh-2022-009378 · Cited by 51
Metadata
- Authors
- McFadyen, C. A., Zeiler, F. A., Newcombe, V., Synnot, A., Steyerberg, E., Gruen, R. L., Rosand, J., Palotie, A., Maas, A. I. R., & Menon, D. K.
- Venue
- Journal of Neurotrauma
- Publisher
- SAGE Publications
- Published
- 2021-04-15
- Volume
- 38
- Issue
- 8
- Pages
- 1124-1136
- ISSN
- 0897-7151 (ISSN-L)
- 1557-9042
- OpenAlex
- W2921483182
- Cited by
- 90
- References
- 13
- FWCI
- 2.30
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Apolipoprotein E4 Polymorphism and Outcomes from Traumatic Brain Injury: A Living Systematic Review and Meta-Analysis. https://app.cochat.ai/papers/10.1089/neu.2018.6052
- The paper
- McFadyen, C. A., Zeiler, F. A., Newcombe, V., Synnot, A., Steyerberg, E., Gruen, R. L., Rosand, J., Palotie, A., Maas, A. I. R., & Menon, D. K. (2021). Apolipoprotein E4 Polymorphism and Outcomes from Traumatic Brain Injury: A Living Systematic Review and Meta-Analysis. Journal of Neurotrauma. https://doi.org/10.1089/neu.2018.6052
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.